Compare SFL & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFL | EVO |
|---|---|---|
| Founded | 2003 | 1993 |
| Country | Bermuda | Germany |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | 2021 |
| Metric | SFL | EVO |
|---|---|---|
| Price | $7.62 | $2.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $11.00 | $7.00 |
| AVG Volume (30 Days) | ★ 1.2M | 115.9K |
| Earning Date | 11-11-2025 | 11-05-2025 |
| Dividend Yield | ★ 14.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $774,521,000.00 | ★ $887,396,457.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.73 | $2.84 |
| 52 Week High | $11.14 | $5.10 |
| Indicator | SFL | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 37.92 | 39.51 |
| Support Level | $8.24 | $2.94 |
| Resistance Level | $7.90 | $3.09 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 13.33 | 19.39 |
SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.